Genetic Engineering Vaccine of Toxoplasma Gondii

China Biotechnology

2009, Vol. 29

Issue (11): 102-105 DOI:

Genetic Engineering Vaccine of Toxoplasma Gondii

XU An-jian, GU Jun-chao

Beijing Tropical Disease Institute，Beijing Friendship Hospital, Beijing 100050,China

Download:

HTML

PDF(353KB) HTML
Export: BibTeX | EndNote (RIS)

Abstract

The Toxoplasma gondii vaccine is the best way to prevent Toxoplasma gondii infection. The improvement of the biological techology promots the study of Toxoplasma gondii vaccine. The newest study progresses of Toxoplasma gondii genetic engineering vaccine, which is summarized on the basis of the current study results, is respected to provide new aspects of the Toxoplasma gondii vaccine study for the researches.

Key words： Toxoplasma gondii Genetic engineering vaccine

Received: 03 August 2009 Published: 07 December 2009

ZTFLH:

Q789

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XU An-Jian
	GU Dun-Chao

Cite this article:

XU An-Jian, GU Dun-Chao. Genetic Engineering Vaccine of Toxoplasma Gondii. China Biotechnology, 2009, 29(11): 102-105.

URL:

https://manu60.magtech.com.cn/biotech/ OR https://manu60.magtech.com.cn/biotech/Y2009/V29/I11/102


［1］	MH el Kouni. Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy. Curr Pharm Des, 2007,13(6): 581~597

［2］	Jongert E, Roberts C W, Gargano N, et al. Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz, 2009, 104(2): 252~266

［3］	Bout D T, Mevelec M N, VelgeRoussel F, et al. Prospects for a human Toxoplasma vaccine. Curr Drug Targets Immune Endocr Metabol Disord, 2002, 2(3): 227~234

［4］	Kasper L H, Bradley M S, Pfefferkorn E R, et al. Identification of stagespecific sporozoite antigens of Toxoplasma gondii by monoclonal antibodies. J Immunol, 1984, 132: 443~449

［5］	Partanen J, Braekeleer D, Diet R, et al. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. J Clin Microbiol, 1984,20(1): 133~135

［6］	司进，汤俊明，赵松，等.刚地弓形虫RH株主要表面抗原1的原核表达和纯化及免疫反应性检测.中华检测医学杂志，2004，27(2)：107~109 Si J, Tang J M, Zhao S, et al. Chinese Journal of Laboratory Medicine, 2004，27(2)：107~109

［7］	Kim K, Bulow R, Kampmeier J, et al. Conformationally appropriate expression of the Toxoplasma gondii SAG1(P30) in CHO cells. Infect Immun, 1994,62: 203~209

［8］	Liu Q, Gao S, Jiang L, Shang L, et al. A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice. Microbes Infect, 2008, 10(12,13): 1355~1362

［9］	Aline F, Bout D, Amigorena S, et al. Toxoplasma gondii antigenpulseddendritic cellderived exosomes induce a protective immune response againsr T. gondii infection. Infect Immun, 2004, 72(7): 4127~4137

［10］	Garcia J L, Navarro I T, Biazzono L, et al. Protective activity against oocyst shedding in cats vaccinated with crude rhoptry proteins of the Toxoplasma gondii by the intranasal route. Vet Parasitol, 2007, 145(3,4): 197~206

［11］	Leyva R, Herion P, Saacedra R. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitol Res, 2001, 87(1): 70~79

［12］	Tait E D, Hunter C A. Advances in understanding immunity to Toxoplasma gondii. Mem Inst Oswaldo Cruz, 2009, 104(2): 201~210

［13］	杨婷婷，何深一，蒋华，等.弓形虫主要表面抗原P30单价及复合基因疫苗的构建.中国寄生虫学与寄生虫病杂志，2005，23(1)：14~17 Yang T T, He S Y, Jiang H, et al. Chinese Journal of Parasitology and Parasitic Diseases, 2005，23(1)：14~17

［14］	Igarashi M, Kano F, Tamekuni K, et al. Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice. Exp Parasitol, 2008, 118(3): 386~392

［15］	张佃波，周林涛，王海防，等.刚地弓形虫ROPP30复合重组蛋白疫苗对BLAB/c小鼠免疫保护性的研究.中国病原生物学杂志，2008，3(10): 763~767 Zhang X B, Zhou L T, Wang H F, et al. Journal of Parasitic Biology, 2008，3(10): 763~767

［16］	Debard N, BuzoniGatel D, Bout D. Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebal cysts after oral infection. Infect Immun, 1996, 64(6): 2158~2166

［17］	MartinezGomez F, GarciaGonzalez L F, MondragonFlores R, et al. Protection against Toxoplasma gondii brain cyst formation in mice immunized with Toxoplasma gondii cytoskeleton proteins and Lactobacillus casei as adjuvant. Vet Parasitol, 2009, 160(3,4): 311~315

［18］	Hedhli D, DimierPoisson I, Judge J W, et al. Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilinlike protein as an adjuvant. Vaccine, 2009, 27(16): 2274~2281

［19］	MoralesSainz L, EscobarRamirez A, CruzTorres V, et al. The polypeptides COX2A and COX2B are essential components of the mitochondrial cytochrome coxidase of Toxoplasma gondii. Biochim Biophys Acta, 2008, 1777(2): 202~210

[1]	XIA Wen-yue, WANG Jing, ZHAO Bing-xin, PAN Xiao-xia, WEN Yu-ling, CHEN Yuan-ding . Comparative Analysis of Two Rotavirus VP4 Epitopes Inserted on the Same Site of VP6 Vector Protein[J]. China Biotechnology, 2015, 35(8): 9-15.

[2]	WAN Fang, ZHANG Bin, CHEN Min-liang, CHEN Jin-cong, CHEN Xue-lan . Effects of proC and putP Deletion on Physiological Metabolism of L-arginine-producing Strain Corynebacterium crenatum[J]. China Biotechnology, 2015, 35(8): 51-58.

[3]	CHANG Yu-mei, HOU Zhan-ming . Research on Gene Knockout and Function of FgPDE1 in Fusarium graminearum[J]. China Biotechnology, 2015, 35(8): 59-67.

[4]	GAO Fei, ZHOU Jing, LIU Xiao-tong, LI Cheng-lei, YAO Hui-peng, ZHAO Hai-xia, WU Qi . *Cloning and Expression Analysis One Zinc Finger Protein Gene FtLOL1* in Fagopyrum tataricum: Effect of Abiotic Stress**[J]. China Biotechnology, 2015, 35(8): 44-50.

[5]	WANG Qing, XU Yan-zhao, WEI Xiao-xiao, WANG Qiu-xia, HANG Bo-lin, SUN Ya-wei, WANG Fei-fei, HU Jian-he . Preparation of Polyclonal Antiserums of GP5a Protein of Porcine Reproductive and Respiratory Syndrome Virus[J]. China Biotechnology, 2015, 35(8): 38-43.

[6]	SHEN Dong-ling, SHANG Shu-mei, LI Wei-na, YAN Jin-ping, HANGAN Ir-bis. *Characterization of the Disrupted ack* Genes on Fermentation by Thermoanaerobacterium calidifontis Rx1**[J]. China Biotechnology, 2015, 35(7): 37-44.

[7]	LUO Wan-yue, LI Tian-ming, YU Ying, XU Mei-xue, YI Hong. *Construction of an Inducible Expression Shuttle Vector for Ketogulonigenium vulgare* Allowing Tightly Regulable Gene Expression**[J]. China Biotechnology, 2015, 35(5): 81-86.

[8]	GONG Long-cai, LUO Zhen-ming, YANG Yan-qing, WANG Zhen-yu, XIANG Jun-jian, WANG Hong. Prokaryotic Expression and Identification of cTnI-linker-TnC Fusion Protein[J]. China Biotechnology, 2015, 35(4): 48-53.

[9]	CHEN Jing-jing, XING Gui-chun, ZHANG Ling-qiang. Generation of FBXL15 Conditional Knockout Mice Using the Loxp-Cre Strategy[J]. China Biotechnology, 2015, 35(4): 74-79.

[10]	FANG Shi-xiong, MA Yi, SHEN Shu-tao, ZHAO Shao-jun, HONG An. Efficient Preparation of TNFα Derivatives TRSP10 and Preliminary Study of Its Inhibitory Effect on Prostate Cancer DU145 Cells[J]. China Biotechnology, 2015, 35(4): 11-16.

[11]	WANG Xiao-yan, CHEN Na-zi, AI Jun, ZHAO Yang, WU Mei-yu, HUANG Jin-zhi, JIANG Chao, LI Xiao-kun. Expression and Purification of Biological-active Recombinant HBV Precore Protein-Mouse IgG Fc Based on Baculovirus Expression Vector System[J]. China Biotechnology, 2015, 35(4): 42-47.

[12]	XIAO Shi-yuan, XU Jing-liang, CHEN Xiao-yan, YANG liu, YUAN Zhen-hong. *Production of the Isoamyl Alcohol in E.coli* by Expression of kivD Gene**[J]. China Biotechnology, 2015, 35(4): 60-65.

[13]	LIU Ya-long, YAN Dong-ming, WENG Liang, ZOU Xue, LIU Dan, PENG Chao, SU Ya-nan, YAN Jin-jin, ZHANG Jing, GUO Zhi-yan. *Pilot-scale Fermentation and Purification of a Recombinant E. coli* Heat-labile Enterotoxin B Subunit**[J]. China Biotechnology, 2015, 35(2): 78-83.

[14]	LI Ming, WANG Yong-fei, JIAO Jin-xia, YANG Yang, ZHANG Ning, XING Xiang-bin, MA San-mei. The Expression of OPCML in Gastric Cancer and Role of OPCML in Biological Function of Gastric Cancer Cell[J]. China Biotechnology, 2015, 35(2): 1-7.

[15]	LIU Yang, YANG Ya-lin, ZHANG Yu-ting, RAN Chao, ZHOU Zhi-gang. *Expression, Purification and Characterization of β-N-acetylglucosaminidase from Aeromonas veronii* B565**[J]. China Biotechnology, 2015, 35(2): 38-44.

Viewed

Full text

Abstract

Cited

Shared

Discussed